Cibirelix 0.25mg Injection PFS

Cibirelix 0.25mg Injection PFS are the hormonal agents in the category of gonadotropin-releasing hormone antagonists containing the active ingredient Cetrorelix. It is used to treat female infertility (the inability of a woman to conceive a child or carry a pregnancy to full term). This drug helps to synchronise the development of multiple follicles and ensures that they can be retrieved during the IVF procedure. This drug is contraindicated in individuals with known hypersensitivity or allergy to it or its component. Inform your physician if you have kidney problems and liver problems. Special monitoring or dose adjustments are required in these situations. Cibirelix 0.25mg Injection PFS is often used with other medications to stimulate the ovaries as part of fertility treatment. It can mainly increase the chance of developing Ovarian Hyperstimulation Syndrome (OHSS), a condition in which the ovaries become enlarged, and cysts may form. Contact your physician if you experience severe pelvic pain, bloating, nausea, vomiting, or sudden weight gain, as these symptoms may indicate OHSS. Report to your physician immediately if you experience sudden life-threatening allergic reactions such as difficulty breathing or wheezing, swelling, rash, itching, fever, and chills. This drug is not intended for use in children. Please inform your physician about any other medications you use, have recently used, or may use, as they can interact with Cetrorelix. The use of this drug in pregnant and breastfeeding women is not recommended. Consult your doctor for more advice before initiating the treatment.